James Maw

Success or failure of these mega-IPOs is critical but, ironically, many of the incumbents backing these companies are raising capital themselves at the same time. Can public markets support both? There is a smart piece by Emily Zheng at Pitchbook, Eggs in... See more

Boston Scientific is taking a leaf from the IT sector in using corporate venture deals for acqui-hire and product optionality. New York-listed medical device company Boston Scientific under senior vice president Charlie Attlan has been a strategic corpora... See more

AMD's purchase of a stake in publicly-listed rival Marvell is a move that borrows from CVC's ecosystem investment approach. We are seeing some interesting uses of corporate venture capital-style techniques to invest in strategic competitors’ public stock.... See more

From the August 1986 Issue LR Sign Up to our newsletter Receive free articles, highlights from the archive, news, details of prizes, and much more. @Lit_Review Follow Literary Review on Twitter Twitter Feed For years, the classical tradition has trained f... See more